SEK 0.01
(-2.78%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 554 Thousand SEK | -16.94% |
2022 | 667 Thousand SEK | -23.04% |
2021 | 866.66 Thousand SEK | 0.0% |
2020 | - SEK | 0.0% |
2019 | - SEK | 0.0% |
2018 | - SEK | 0.0% |
2017 | - SEK | -100.0% |
2016 | 12.16 Million SEK | 0.0% |
2015 | - SEK | 0.0% |
2014 | - SEK | 0.0% |
2013 | - SEK | 0.0% |
2012 | - SEK | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 479 Thousand SEK | -5.71% |
2024 Q2 | - TRY | -100.0% |
2023 FY | 554 Thousand SEK | -16.94% |
2023 Q1 | 617 Thousand SEK | -7.5% |
2023 Q2 | 583 Thousand SEK | -5.51% |
2023 Q3 | 554 Thousand SEK | -4.97% |
2023 Q4 | 508 Thousand SEK | -8.3% |
2022 Q1 | 867 Thousand SEK | 0.04% |
2022 Q3 | 733 Thousand SEK | -12.0% |
2022 FY | 667 Thousand SEK | -23.04% |
2022 Q4 | 667 Thousand SEK | -9.0% |
2022 Q2 | 833 Thousand SEK | -3.92% |
2021 Q4 | 866.66 Thousand SEK | -13.33% |
2021 Q2 | - SEK | 0.0% |
2021 Q3 | 1 Million SEK | 0.0% |
2021 FY | 866.66 Thousand SEK | 0.0% |
2020 Q2 | - SEK | 0.0% |
2020 Q4 | - SEK | 0.0% |
2020 FY | - SEK | 0.0% |
2019 Q4 | - SEK | 0.0% |
2019 FY | - SEK | 0.0% |
2019 Q2 | - SEK | 0.0% |
2018 FY | - SEK | 0.0% |
2018 Q4 | - SEK | 0.0% |
2018 Q2 | - SEK | 0.0% |
2017 Q2 | - SEK | 0.0% |
2017 FY | - SEK | -100.0% |
2017 Q4 | - SEK | 0.0% |
2016 FY | 12.16 Million SEK | 0.0% |
2016 Q4 | 12.16 Million SEK | 0.0% |
2016 Q2 | 12.16 Million SEK | 0.0% |
2015 Q4 | - SEK | 0.0% |
2015 Q2 | - SEK | 0.0% |
2015 FY | - SEK | 0.0% |
2014 Q4 | - SEK | 0.0% |
2014 FY | - SEK | 0.0% |
2013 FY | - SEK | 0.0% |
2012 FY | - SEK | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Aino Health AB (publ) | 164 Thousand SEK | -237.805% |
Kontigo Care AB (publ) | 3.67 Million SEK | 84.925% |
Medhelp Care Aktiebolag (publ) | - SEK | -Infinity% |
RaySearch Laboratories AB (publ) | 431.97 Million SEK | 99.872% |
Surgical Science Sweden AB (publ) | 40.02 Million SEK | 98.616% |